Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Why Micron (MU) Might be Well Poised for a Surge
Why Micron (MU) Might be Well Poised for a Surge

Micron (MU) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts

KB Home Q4 Earnings & Revenues Beat Estimates, Both Decline Y/Y
KB Home Q4 Earnings & Revenues Beat Estimates, Both Decline Y/Y

KB Home KBH reported fourth-quarter fiscal 2025 results. The quarter’s earnings and total revenues surpassed the Zacks Consensus Estimate but decreased on a year-over-year basis.

KB Home’s quarterly

Equinor Taps Deepsea Aberdeen for Drilling Operations Offshore Norway
Equinor Taps Deepsea Aberdeen for Drilling Operations Offshore Norway

Equinor ASA EQNR, a Norwegian integrated energy company, has awarded a contract to Odfjell Drilling, an offshore drilling contractor, for its Deepsea Aberdeen drillship for work on the Norwegian

Subsea7 Secures EPCI Contract From ConocoPhillips Offshore Norway
Subsea7 Secures EPCI Contract From ConocoPhillips Offshore Norway

Subsea7 SUBCY has been awarded a contract for the development of the Previously Produced Fields (“PPF”) offshore Norway by ConocoPhillips COP. Per the terms of the contract, Subsea7 will carry out

Palantir Stock's Valuation: Overstretched or Rightfully Earned?
Palantir Stock's Valuation: Overstretched or Rightfully Earned?

Palantir Technologies PLTR has emerged as one of the most talked-about names in the S&P 500, and not just for what it does, but for what investors are willing to pay for it. With a market

Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates
Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates

Viatris Inc. VTRS recently announced four regulatory achievements across multiple stages of its pipeline.

These achievements outline the company’s R&D progress in 2025. VTRS will continuously work

Tech ETFs to Buy as Micron Rallies 10% Post Q1 Earnings Beat
Tech ETFs to Buy as Micron Rallies 10% Post Q1 Earnings Beat

Shares of Micron Technology Inc. MU rose 10.1% on the bourses during the last trading session after releasing better-than-expected first-quarter fiscal 2026 results. The company surpassed analysts’

Pharma's $370B Bet on America: The ETF Plays for 2026
Pharma's $370B Bet on America: The ETF Plays for 2026

The U.S. pharmaceutical industry underwent a historic, policy-driven transformation in 2025. After a period of post-pandemic cooling, the industry demonstrated stark improvement, ignited by a

Bank ETFs Shine as US Banking Profit Hits Decade High in Q3
Bank ETFs Shine as US Banking Profit Hits Decade High in Q3

The U.S. banking industry is closing 2025 on a powerful note, with third-quarter profitability having reportedly reached its highest level in over a decade (as per a recent report by the S&P Global

How Celebrity Involvement Can Increase Brand and Company Value
How Celebrity Involvement Can Increase Brand and Company Value
When companies work with celebrities, it tends to be the case that the outcome is limited to visibility. A face randomly appears, there’s a brief spike in attention, and then the partnership just
WULF vs. RIOT: Which Bitcoin Miner Stock Is the Smarter Investment?
WULF vs. RIOT: Which Bitcoin Miner Stock Is the Smarter Investment?

The Bitcoin mining sector is in a transition phase as operators are increasingly focusing on digital infrastructure and AI hosting to diversify revenues. TeraWulf WULF and Riot Platforms RIOT are

Carnival Q4 Earnings Beat Estimates, Revenues Increase Y/Y
Carnival Q4 Earnings Beat Estimates, Revenues Increase Y/Y

Carnival Corporation & plc CCL reported fourth-quarter fiscal 2025 (ended Nov. 30, 2025) results, with adjusted earnings beating the Zacks Consensus Estimate and revenues missing the same. The top

Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know
Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know

Palisade Bio, Inc. (PALI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which

Are You Looking for a Top Momentum Pick? Why KeyCorp (KEY) is a Great Choice
Are You Looking for a Top Momentum Pick? Why KeyCorp (KEY) is a Great Choice

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Are You Looking for a Top Momentum Pick? Why Astronics Corporation (ATRO) is a Great Choice
Are You Looking for a Top Momentum Pick? Why Astronics Corporation (ATRO) is a Great Choice

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

AtriCure (ATRC) Is Up 6.32% in One Week: What You Should Know
AtriCure (ATRC) Is Up 6.32% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

All You Need to Know About Curtiss-Wright (CW) Rating Upgrade to Buy
All You Need to Know About Curtiss-Wright (CW) Rating Upgrade to Buy

Investors might want to bet on Curtiss-Wright (CW), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

What Makes Symrise (SYIEY) a New Buy Stock
What Makes Symrise (SYIEY) a New Buy Stock

Symrise AG Unsponsored ADR (SYIEY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful

SPX Technologies (SPXC) is a Great Momentum Stock: Should You Buy?
SPX Technologies (SPXC) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

MGIC Investment (MTG) is a Great Momentum Stock: Should You Buy?
MGIC Investment (MTG) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

What Makes Curbline (CURB) a New Buy Stock
What Makes Curbline (CURB) a New Buy Stock

Curbline Properties (CURB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings

Cemex (CX) is a Great Momentum Stock: Should You Buy?
Cemex (CX) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

RBB (RBB) Upgraded to Strong Buy: What Does It Mean for the Stock?
RBB (RBB) Upgraded to Strong Buy: What Does It Mean for the Stock?

Investors might want to bet on RBB (RBB), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one

Orla Mining Ltd. (ORLA) is a Great Momentum Stock: Should You Buy?
Orla Mining Ltd. (ORLA) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Lifevantage (LFVN) Upgraded to Buy: Here's What You Should Know
Lifevantage (LFVN) Upgraded to Buy: Here's What You Should Know

Lifevantage (LFVN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one